These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 21042052

  • 1. The last decade of microbicide clinical trials in Africa: from hypothesis to facts.
    Ramjee G, Kamali A, McCormack S.
    AIDS; 2010 Oct; 24 Suppl 4():S40-9. PubMed ID: 21042052
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J, Mwethera PG, Wiysonge CS.
    Cochrane Database Syst Rev; 2012 Jun 13; (6):CD007961. PubMed ID: 22696373
    [Abstract] [Full Text] [Related]

  • 4. Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.
    Obiero J, Mwethera PG, Hussey GD, Wiysonge CS.
    BMC Infect Dis; 2012 Nov 06; 12():289. PubMed ID: 23130761
    [Abstract] [Full Text] [Related]

  • 5. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR, Kiser PF.
    Antiviral Res; 2013 Sep 06; 99(3):391-400. PubMed ID: 23845918
    [Abstract] [Full Text] [Related]

  • 6. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 Sep 06; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
    Miller L, Prieto Merino D, Baisley K, Hayes R.
    PLoS One; 2022 Sep 06; 17(5):e0267011. PubMed ID: 35551324
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of vaginal microbicides in preventing HIV transmission.
    Musekiwa A, Fernando NB, Abariga SA.
    Trop Med Int Health; 2020 Jul 06; 25(7):790-802. PubMed ID: 32306503
    [Abstract] [Full Text] [Related]

  • 10. Microbicides: putting women in control.
    Forbes A.
    WORLD; 1998 Sep 06; (89):4-5. PubMed ID: 11365770
    [Abstract] [Full Text] [Related]

  • 11. Twice-daily application of HIV microbicides alter the vaginal microbiota.
    Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.
    mBio; 2012 Dec 18; 3(6):. PubMed ID: 23249810
    [Abstract] [Full Text] [Related]

  • 12. Microbicide clinical trial adherence: insights for introduction.
    Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, Tolley E, McCormack S.
    J Int AIDS Soc; 2013 Apr 08; 16(1):18505. PubMed ID: 23561044
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Should microbicides be controlled by women or by physicians?
    Piret J, Bergeron MG.
    Int J Infect Dis; 2010 Sep 08; 14 Suppl 3():e14-7. PubMed ID: 20932483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific microbicides in the prevention of HIV infection.
    Kelly CG, Shattock RJ.
    J Intern Med; 2011 Dec 08; 270(6):509-19. PubMed ID: 21917029
    [Abstract] [Full Text] [Related]

  • 19. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA, Baxter C.
    Expert Rev Anti Infect Ther; 2013 Jan 08; 11(1):13-23. PubMed ID: 23428099
    [Abstract] [Full Text] [Related]

  • 20. Microbicides for HIV prevention.
    Ramjee G.
    Indian J Med Res; 2011 Dec 08; 134(6):930-8. PubMed ID: 22310825
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.